ISRCTN ISRCTN92903493
DOI https://doi.org/10.1186/ISRCTN92903493
Protocol serial number 12054
Sponsor Robert Jones & Agnes Hunt Orthopaedic & District Hospital
Funder Smith & Nephew Medical Ltd
Submission date
05/09/2012
Registration date
10/09/2012
Last edited
16/04/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Suheer Karlakki
Scientific

Robert Jones & Agnes Hunt Orthopaedic & District Hospital
Twmpath Lane
Oswestry
SY10 7AG
United Kingdom

Phone +44 1691 404344
Email sudheer.karlakki@rjah.nhs.uk

Study information

Primary study designInterventional
Study designRandomised interventional trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleEvaluation of a postoperative wound management protocol using negative pressure wound therapy in primary arthroplasty patients
Study objectivesMost postoperative protocols for patients undergoing primary total hip and knee replacements (arthroplasty) require the patient to have a dry wound before being discharged from hospital. This has recently become more important following the introduction of strict guidelines surrounding the use of heparin (a bloodthinning treatment) to reduce the risk/occurence of postoperative blood clots. Oozing from wound sites following such surgery continues to be a common complication in a large number of patients with a resulting delay in hospital discharge and inconvenience to the patient. This increase in stay incurs extra costs on the various trusts and the NHS. The use of Negative Pressure Wound Therapy (NPWT) is a relative recent idea which has shown very promising results in trauma surgery and other fields of surgery. However, there is very limited literature relating to its efficacy and costeffectiveness in arthroplasty surgery. Arthroplasty patients appear to be the ideal candidate for NPWT. Using the standard method of dressings, patients may require multiple changes of dressing and therefore early exposure of the wound. However, due to the mild to moderate nature of wound oozing in arthroplasty patients, is it thought that a single application of PICO dressing is sufficient for the whole period of wound healing.

More details can be found at http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12054
Ethics approval(s)First MREC, 18 May 2012, ref: 12/SW/0094
Health condition(s) or problem(s) studiedMusculoskeletal surgery
InterventionControl group
The control group will receive the standard dressings post-operatively

Study group
The study group will receive PICO negative pressure wound therapy post-operatively for 7 days
Intervention typeProcedure/Surgery
Primary outcome measure(s)

To introduce a new post-operative wound management protocol based on using PICO NPWT.

Key secondary outcome measure(s)

No secondary outcome measures

Completion date16/08/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration220
Key inclusion criteria1. Patients undergoing primary total hip or knee replacement
2. Patients with no contraindications for PICO NPWT or standard postoperative dressings
3. Patients who are over 18 years of age and have given informed consent to participant
4. Male and female participants
Key exclusion criteria1. Patients undergoing revision arthroplasty surgery
2. Patients with a known history of poor compliance with medical treatment
3. Patients with known allergies to either product components (silicone adhesives and polyurethane films (direct
contact with incision), acrylic adhesives (direct contact with skin), polyethylene fabrics and superabsorbent powders (polyacrylates)
4. Patients on warfarin therapy (these patients may have an increased exudate and also a prolonged stay in hospital following surgery whilst trying to achieve therapeutic INR (international normalized ratio) levels an indication of how well the patient's blood clots
5. Patients who do not give informed consent to participate in this study
Date of first enrolment16/08/2012
Date of final enrolment16/08/2013

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Robert Jones & Agnes Hunt Orthopaedic & District Hospital
Oswestry
SY10 7AG
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2016 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

16/04/2018: Publication reference added.
10/03/2016: No publications found, verifying study status with principal investigator.